The TRIUMPH program includes eight Phase 3 trials evaluating retatrutide for obesity, type 2 diabetes, osteoarthritis, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and liver disease
When you're considering semaglutide for diabetes or weight management, understanding the prevalence of menstrual irregularities, including missed periods, is crucial
Tesamorelin is contraindicated in patients with active malignancy, pituitary disorders affecting GHRH pathways, pregnancy, and in those with disrupted hypothalamic-pituitary function due to surgery, radiation, or trauma
RCM is a live imaging technology that allows for instant viewing of the epidermis and papillary dermis with nearly histologic resolution